Aquestive Therapeutics Inc
Research Aquestive Therapeutics Inc (AQST) on Bullrun: market cap USD 599.95M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerAQST
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryDrug Manufacturers-Specialty & Generic
- CurrencyUSD
- Market capUSD 599.95M
- Financial periodQ2 2026
- RevenueUSD 13.82M
- Net income-USD 22.86M
- Free cash flow-USD 9.65M
- Gross margin70.9%
Valuation Snapshot
latest market cap is USD 599.95M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 44.55M | -USD 83.78M | -USD 52.99M | 58.3% | -0.78 | USD 121.17M | USD 45.00M | -USD 33.66M |
| FY2024 | USD 57.56M | -USD 44.14M | -USD 35.92M | 69.0% | -0.51 | USD 71.55M | USD 45.00M | -USD 60.16M |
| FY2023 | USD 50.58M | -USD 7.87M | -USD 7.38M | 58.8% | -0.13 | USD 23.87M | USD 45.00M | -USD 106.49M |
| FY2022 | USD 47.68M | -USD 54.41M | -USD 10.84M | 59.3% | -1.12 | USD 27.27M | USD 57.49M | -USD 118.55M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-09 | USD 599.95M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 788.41M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 325.43M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 134.87M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 48.74M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 160.38M | n/a | n/a | n/a |
About Aquestive Therapeutics Inc
Aquestive Therapeutics, Inc. operates as a pharmaceutical company in the United States and internationally. It offers Libervant, a buccal soluble film formulation of diazepam for the treatment of seizures; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; EMYLIF, an oral film formulation of riluzole; ONDIF, an oral soluble film formulation of ondansetron;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Aquestive Therapeutics Inc's market cap?
Aquestive Therapeutics Inc's market capitalization is USD 599.95M.
What does Aquestive Therapeutics Inc do?
Aquestive Therapeutics, Inc. operates as a pharmaceutical company in the United States and internationally. It offers Libervant, a buccal soluble film formulation of diazepam for the treatment of seizures; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; EMYLIF, an oral film formulation of riluzole; ONDIF, an oral soluble film formulation of ondansetron; SYMPAZAN, an oral soluble film formulation of clobazam used for the treatment of seizures associated with a rare, intractable form of epilepsy; KYNMOBI, a sublingual film.